Tech Company Financing Transactions
Obsidio Funding Round
IAG Capital Partners, Good Growth Capital and National Science Foundation participated in a $3 million funding round for Obsidio. The funding round was announced by the company on 8/10/2020.
Transaction Overview
Company Name
Announced On
8/10/2020
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company plans to use the proceeds for clinical development of its embolic hydrogel material.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
1502 Main St
Columbia, SC 29201
USA
Columbia, SC 29201
USA
Phone
Website
Email Address
Overview
Obsidio, Inc. is an early-stage medical device company focused on developing a minimally-invasive occlusive agent using a shear-thinning biomaterial (STB) technology that can stop undesired blood flow through vessels anywhere in the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ehsan Jabbarzadeh
Chief Medical Officer
Rahmi Oklu
Founder
Ali Khademhosseini
Browse more venture capital transactions:
Prev: 8/10/2020: Artemest venture capital transaction
Next: 8/10/2020: ModifyHealth venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs